Cancer Treatment: Psychological Support — House of Commons, 2018-11-22
Topic: Health
Sarah Louise Newton (Conservative, Centre-right): I am sure that I speak for everyone here in congratulating the hon. Member for Alyn and Deeside (Mark Tami) not just on securing such an important debate, but on the bravery he showed in his speech by sharing with the House his family’s experience. It is very important that we bring the voices of the people we all seek to serve in this place into the Chamber, as well as the experiences that were shared from CLIC Sargent and Macmillan, so I thank him for that. I know that he is doing extremely good work through a number of organisations in the House to ensure that cancer patients are getting the very best treatment and support. He has also given a huge amount of support to setting up the all-party group on children, teenagers, and young adults with cancer. Although the hon. Member for Bristol West (Thangam Debbonaire) has left the Chamber, I praise her work on the really good report that she and the hon. Gentleman produced. I read it last night and thoroughly recommend it to other Members. I am standing in for the Under-Secretary of State for Health and Social Care, my hon. Friend the Member for Winchester (Steve Brine), who has ministerial responsibility for cancer. He is very sorry that he cannot be here this evening and he was very pleased to be able to contribute to the APPG’s report. He asked me to remind the House that he has agreed to respond to everything—all the recommendations—in the report, so the hon. Member for Alyn and Deeside will get a full written response from him I am pleased to respond on the Government’s behalf to this debate, because it brings together two vital issues, which are crucial to the health of the nation and are at the top of the Government’s priority list. Approximately one in four people in the UK experience a mental health problem every year. In England, one in six people report experiencing a common mental health problem, such as anxiety and depression, in any given week. Cancer affects one in two of us—there will not be anyone here this evening who has not been dreadfully affected by this disease—so it is absolutely important that the Government are focusing on these priorities Since 2010, cancer survival rates have been improving year on year. We estimate that some 7,000 people are alive today who would not have been here just 18 years ago, but we are not at all complacent. We know that there is more to do to make sure that our results are the best in the world. That is why last month the Prime Minister announced a package of measures, which will be rolled out across the country and which aim to see three quarters of all cancers detected in the earliest stages by 2028. The plan, backed by a record level of investment in the NHS—an extra £20 billion a year by 2023—will radically overhaul screening programmes and provide new investment in state-of-the-art technology to transform the process of diagnosis and boost research and innovation However, what I really want to talk about in the few moments available to me is the support that we must give to people who are living with and beyond cancer. The recovery package, which is a key component of that priority, consists of a set of four interventions that are designed to help patients and clinicians to assess patients’ holistic needs and plan appropriately for their care and support. They include a holistic needs assessment and a care plan, which guide conversations about patient’s holistic needs—not just physical and psychosocial needs, but financial, social and mental health needs. An HNA should take place within 31 days of diagnosis and at the end of each acute phase of treatment, and the care plan should be updated on each occasion. Both interventions enable patients to be referred to appropriate psychological support when necessary That personalised follow-up and support to help people to live well with and beyond cancer is a crucial element of the cancer strategy, and helps us to create the world-class cancer services to which we aspire. NHS England will roll out recovery packages nationwide by 2020, so that the support that they provide is available to all cancer patients in England regardless of where they live. All Cancer Alliances are receiving the necessary funding this year to support full implementation of the recovery package As the hon. Gentleman has said, some cancers, such as chronic blood cancers, can sadly never be cured. Blood cancer patients are frequently on a regime of "watch and wait", often over many years, to establish whether their cancer has progressed to a point at which treatment needs to begin. Understandably, that can take a huge psychological toll on not only patients but their families, which is why the recovery package takes a holistic approach and fully considers the patient’s mental health needs. The package is already being commissioned and delivered, in full or in part, by many clinical commissioning groups across England, but NHS England’s aim is to accelerate the process to ensure full implementation by 2020 so that every cancer patient is given that full package of care Of course we need to ensure that cancer patients, and their families and carers, can access appropriate mental health services if and when they need such support, which is why the Prime Minister has made improving access to mental health services an absolute priority for her Government. There has been a fivefold increase in the number of people accessing Talking Therapies since 2009-10, and that is excellent progress, but we are not complacent; we know that much work needs to be done. In July last year, the Government announced an additional £1.3 billion to expand the mental health workforce and allow the NHS to treat an extra 1 million patients by 2020-21. That will help to ensure that cancer patients can be referred promptly to any psychological support that they need as part of their recovery package. We know that clinical nurse specialists can provide not just clinical but crucial emotional support for cancer patients as they go through cancer treatment, and—often more important—in the follow-up after their treatment.